BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24597765)

  • 1. Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option?
    Calò PG; Medas F; Santa Cruz R; Podda F; Erdas E; Pisano G; Nicolosi A
    BMC Surg; 2014 Mar; 14():12. PubMed ID: 24597765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologically Indeterminate Follicular Thyroid Nodule on Fine Needle Aspiration Cytology is an Indication for Total Thyroidectomy.
    Mahmud F; Siddique AB; Alam F; Siddique MI
    Mymensingh Med J; 2019 Apr; 28(2):434-440. PubMed ID: 31086163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
    Mihai R; Parker AJ; Roskell D; Sadler GP
    Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
    Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
    JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
    Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
    Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
    Batawil N; Alkordy T
    Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
    Sahin M; Gursoy A; Tutuncu NB; Guvener DN
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do sonographic and cytological features predict malignancy in cytologically indeterminate thyroid nodules?
    Dutta S; Thaha MA; Smith DM
    Ann R Coll Surg Engl; 2011 Jul; 93(5):361-4. PubMed ID: 21943458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
    De Napoli L; Bakkar S; Ambrosini CE; Materazzi G; Proietti A; Macerola E; Basolo F; Miccoli P
    Thyroid; 2016 Mar; 26(3):390-4. PubMed ID: 26548748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
    Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
    J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm".
    Kim ES; Nam-Goong IS; Gong G; Hong SJ; Kim WB; Shong YK
    Korean J Intern Med; 2003 Jun; 18(2):94-7. PubMed ID: 12872446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
    Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
    Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, treatment, and outcome of follicular thyroid carcinoma.
    Emerick GT; Duh QY; Siperstein AE; Burrow GN; Clark OH
    Cancer; 1993 Dec; 72(11):3287-95. PubMed ID: 8080485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False negative cytology in large thyroid nodules.
    Giles WH; Maclellan RA; Gawande AA; Ruan DT; Alexander EK; Moore FD; Cho NL
    Ann Surg Oncol; 2015 Jan; 22(1):152-7. PubMed ID: 25074665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of malignancy within cytologically indeterminate thyroid nodules.
    Miller B; Burkey S; Lindberg G; Snyder WH; Nwariaku FE
    Am J Surg; 2004 Nov; 188(5):459-62. PubMed ID: 15546550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. McGill Thyroid Nodule Score in Differentiating Benign and Malignant Pediatric Thyroid Nodules: A Pilot Study.
    Canfarotta M; Moote D; Finck C; Riba-Wolman R; Thaker S; Lerer TJ; Payne RJ; Cote V
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):589-595. PubMed ID: 28653562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
    Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
    Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
    Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
    Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.